Found 7 matching trials
Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density
PHASE2To determine the effect of denosumab treatment compared with placebo over 1...
Location
Multiple Locations
A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects
PHASE2The primary objective of this study is to assess the effect of AMG 162 (den...
Location
Multiple Locations
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
N/AThe purpose of this study is to assess percentage reduction in the of urine...
Location
University of Colorado Hospital
Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)
PHASE4The aims of ZOLARMAB2 are fourfold. First, the investigators want to invest...
Status
Active Not Recruiting
Location
Aarhus University Hospital
Contribution of Bone to Urine Citrate
N/AIdentification of the mechanisms by which bone contributes to urine citrate...
Status
Enrolling By Invitation
Location
UT Southwestern Medical Center
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
PHASE2This is a single-institution, phase 2 trial of zanzalintinib plus investiga...
Location
University of California, San Francisco
Markers of Osteoporosis in Cystic Fibrosis
PHASE4Main Study Up to 100 subjects, both non-CF volunteers and Cystic Fibrosis (...
Location
UT Southwestern Medical Center